rilotumumab previously human monoclonal antibody designed treatment solid rilotumumab development amgen inc november amgen announced halted clinical trials compound advanced gastric cancer including two phase iii studies one trials found increase number deaths taking rilotumumab chemotherapy compared administered monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikirilotumumab